Secondary Prevention Using Cholesterol-Lowering Medications in Patients with Prior Atherosclerotic Cardiovascular Disease Events: A Retrospective Cohort Analysis
**Background:** Secondary prevention with lipid-lowering medications in patients with atherosclerotic cardiovascular disease (ASCVD) is known to reduce the risk of clinical events and death. Current guidelines codify recommendations for implementing secondary prevention in appropriate patients. Howe...
Saved in:
Main Authors: | Xue Han, Steven Fox, Michelle Chu, Jeff McCombs |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2022-01-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.28934 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multimorbidity in Atherosclerotic Cardiovascular Disease and Its Associations With Adverse Cardiovascular Events and Healthcare Costs: A Real-World Evidence Study
by: Dingwei Dai, et al.
Published: (2024-03-01) -
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis
by: Aldo Bonaventura, et al.
Published: (2016-01-01) -
Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study
by: Gehendra Mahara, et al.
Published: (2022-07-01) -
A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
by: Abrar Al Jassim, et al.
Published: (2018-05-01) -
Association of glucose to lymphocyte ratio with the risk of death in patients with atherosclerotic cardiovascular disease
by: Jinglin Lei, et al.
Published: (2025-01-01)